The Use of LDN for Ophthalmic Conditions - Sebastian Denison, Pharm (2021 Conference) (LDN, low dose naltrexone)

This talk is about how they utilize LDN, their LDN protocol, and their outcomes and expectations. The information presented about humans can apply to animals as well.

Autoimmune thyroiditis Part 3 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information. 

Autoimmunity in Families - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Nuts and Bolts of The Thyroid Gland: Therapeutic Targets by Sarah Zielsdorf, MD (2021 Conference) (LDN, low dose naltrexone)

Scott Zashin, MD - Treatment of Sjogren's Syndrome with LDN (2019 Conference) (LDN, low dose naltrexone)

Andy Stein, PharmD - LDN for Ophthalmic use (2019 Conference) (Low dose naltrexone) from LDN Research Trust on Vimeo.